Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/bonk-price-prediction-is-this-the-meme-coin-that-surpasses-shib/